期刊
ACTA NEUROPATHOLOGICA COMMUNICATIONS
卷 8, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s40478-020-01026-0
关键词
Synucleinopathies; Parkinson's disease; Dementia with Lewy bodies; Alpha-synuclein; Lewy body; Trans-synaptic spread; Neurodegeneration
资金
- NIH [NS102227, NS096190, NS061800, T32AG055378, F32EY029974]
- Collins Medical Trust Grants
- American Speech-Language Hearing Foundation New Investigator Grant
- American Parkinson Disease Association
- United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development [I01 BX000552, I01 BX001643]
- OHSU SOM Research Core Initiative Grant
It is necessary to develop an understanding of the specific mechanisms involved in alpha-synuclein aggregation and propagation to develop disease modifying therapies for age-related synucleinopathies, including Parkinson's disease and Dementia with Lewy Bodies. To adequately address this question, we developed a new transgenic mouse model of synucleinopathy that expresses human A53T SynGFP under control of the mouse prion protein promoter. Our characterization of this mouse line demonstrates that it exhibits several distinct advantages over other, currently available, mouse models. This new model allows rigorous study of the initial location of Lewy pathology formation and propagation in the living brain, and strongly suggests that aggregation begins in axonal structures with retrograde propagation to the cell body. This model also shows expeditious development of alpha-synuclein pathology following induction with small, in vitro-generated alpha-synuclein pre-formed fibrils (PFFs), as well as accelerated cell death of inclusion-bearing cells. Using this model, we found that aggregated alpha-synuclein somatic inclusions developed first in neurons, but later showed a second wave of inclusion formation in astrocytes. Interestingly, astrocytes appear to survive much longer after inclusion formation than their neuronal counterparts. This model also allowed careful study of peripheral-to-central spread of Lewy pathology after PFF injection into the hind limb musculature. Our results clearly show evidence of progressive, retrograde trans-synaptic spread of Lewy pathology through known neuroanatomically connected pathways in the motor system. As such, we have developed a promising tool to understand the biology of neurodegeneration associated with alpha-synuclein aggregation and to discover new treatments capable of altering the neurodegenerative disease course of synucleinopathies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据